These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice. Bombardieri S; Ruiz AA; Fardellone P; Geusens P; McKenna F; Unnebrink K; Oezer U; Kary S; Kupper H; Burmester GR; Rheumatology (Oxford); 2007 Jul; 46(7):1191-9. PubMed ID: 17504821 [TBL] [Abstract][Full Text] [Related]
26. [Historical review of rheumatology and future directions]. Kawahata K Nihon Rinsho; 2009 Mar; 67(3):445-57. PubMed ID: 19280915 [TBL] [Abstract][Full Text] [Related]
27. Fifty years of cortisone. Plotz CM J Rheumatol; 2002 Apr; 29(4):853-4. PubMed ID: 11950034 [No Abstract] [Full Text] [Related]
28. Emerging biologic drugs for the treatment of rheumatoid arthritis. Puppo F; Murdaca G; Ghio M; Indiveri F Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092 [TBL] [Abstract][Full Text] [Related]
29. Don't forget traditional DMARDs. Fleischmann R Rheumatology (Oxford); 2011 Mar; 50(3):429-30. PubMed ID: 21339283 [No Abstract] [Full Text] [Related]
30. A century of American rheumatology. Benedek TG Ann Intern Med; 1987 Feb; 106(2):304-12. PubMed ID: 3541728 [TBL] [Abstract][Full Text] [Related]
31. Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior? Rigby WF Nat Clin Pract Rheumatol; 2007 Apr; 3(4):227-33. PubMed ID: 17396108 [TBL] [Abstract][Full Text] [Related]
32. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Sfikakis PP Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395 [TBL] [Abstract][Full Text] [Related]
33. Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents. Bello SL; Serafino L; Bonali C; Terlizzi N; Fanizza C; Anecchino C; Lapaldula G Reumatismo; 2012 Dec; 64(5):299-306. PubMed ID: 23256105 [TBL] [Abstract][Full Text] [Related]
35. [Glucocorticoids: 50 years of their use in rheumatology]. Nasonov EL Ter Arkh; 1999; 71(5):5-9. PubMed ID: 10399220 [No Abstract] [Full Text] [Related]
36. A brief history of the rheumatic diseases. Benedek TG; Rodnan GP Bull Rheum Dis; 1982; 32(6):59-68. PubMed ID: 6762237 [No Abstract] [Full Text] [Related]
37. Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients. Carter CT; Changolkar AK; Scott McKenzie R J Med Econ; 2012; 15(2):332-9. PubMed ID: 22168788 [TBL] [Abstract][Full Text] [Related]
39. Rheumatoid vasculitis treated with infliximab. van der Bijl AE; Allaart CF; Van Vugt J; Van Duinen S; Breedveld FC J Rheumatol; 2005 Aug; 32(8):1607-9. PubMed ID: 16078342 [TBL] [Abstract][Full Text] [Related]
40. What is the future of targeted therapy in rheumatology: biologics or small molecules? Mócsai A; Kovács L; Gergely P BMC Med; 2014 Mar; 12():43. PubMed ID: 24620738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]